Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Castro

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host diseaseJenna D Goldberg, Alex Linker, Deborah Kuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2015
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous LeukemiaDoris M Ponce, Patrick Hilden, Sean M Devlin, et al.
Journal of Clinical Medicine|November 13, 2025
Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic QualityDiego Gómez Abreo, Daniel F Alarcón Cano, Fernando Ayala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantationDoris M Ponce, Junting Zheng, Anne Marie Gonzales, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with MyelofibrosisRoni Tamari, Franck Rapaport, Nan Zhang, et al.
Journal of Neuroinflammation|February 2, 2025
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease modelsFelipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment ResponsePere Barba, Patrick Hilden, Sean M Devlin, et al.
The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
The Journal of Clinical Investigation|November 6, 2019
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantationSusan Prockop, Ekaterina Doubrovina, Stephanie Suser, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host diseaseJenna D Goldberg, Alex Linker, Deborah Kuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2015
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous LeukemiaDoris M Ponce, Patrick Hilden, Sean M Devlin, et al.
Journal of Clinical Medicine|November 13, 2025
Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic QualityDiego Gómez Abreo, Daniel F Alarcón Cano, Fernando Ayala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantationDoris M Ponce, Junting Zheng, Anne Marie Gonzales, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with MyelofibrosisRoni Tamari, Franck Rapaport, Nan Zhang, et al.
Journal of Neuroinflammation|February 2, 2025
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease modelsFelipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment ResponsePere Barba, Patrick Hilden, Sean M Devlin, et al.
The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
The Journal of Clinical Investigation|November 6, 2019
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantationSusan Prockop, Ekaterina Doubrovina, Stephanie Suser, et al.
Pageof 9